Trevor Hallam, Chief Scientific Officer at SUTRO BIOPHARMA, INC. (STRO), sold 7,166 shares at $10.26 ($74K) on 2020-09-28, disclosed to the SEC on 2020-09-28.
Scheduled sale ($74k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.30 | 2,381 | $25K | 33.2% |
| 2 | $10.30 | 3,810 | $39K | 53.2% |
| 3 | $10.26 | 975 | $10K | 13.6% |
| Total | $10.29 avg | 7,166 | $74K | 100% |
| Filing → |
| STRO | SELL | 2020-11-30 | $41K | — | Filing → |
| STRO | SELL | 2020-11-06 | $251K | — | Filing → |
| STRO | SELL | 2020-08-27 | $9K | — | Filing → |